glp-1 agonist and pancreatitis Suspected drug-induced was rare but more common in patients taking agonists than sulfonylureas, a recent analysis of a VA database finds A new study showed that
Description
Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria
Keyence, Laguna Hills, CA)

Quick Answer: GLP-1 receptor agonists produce modest cholesterol reductions (LDL-C by 2-10%, triglycerides by 10-20%) but should complement, not replace, statin therapy for lipid management

triple agonism extends that to three
Summary: Pancreatitis is a rare potential side effect of GLP-1 agonists, though large clinical trials show no definitive causal link and the absolute risk remains low

Mann JF, Hansen T, Idorn T, Leiter LA, Marso SP, Rossing P, et al
